HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peter G Kaufmann Selected Research

4-nitro-3-dimethylaminopropiophenone

11/2021Patient-Centered Goal-Setting in the National Diabetes Prevention Program: A Pilot Study.
6/2020Enhanced Enrollment in the National Diabetes Prevention Program to Increase Engagement and Weight Loss for the Underserved: Protocol for a Randomized Controlled Trial.
1/2019Presessions to the National Diabetes Prevention Program May be a Promising Strategy to Improve Attendance and Weight Loss Outcomes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Peter G Kaufmann Research Topics

Disease

4Weight Loss (Weight Reduction)
11/2021 - 11/2018
2Cardiovascular Diseases (Cardiovascular Disease)
11/2018 - 07/2005
2Infarction (Infarctions)
01/2017 - 06/2003
2Hypertension (High Blood Pressure)
01/2017 - 07/2004
2Myocardial Infarction
07/2005 - 07/2004
2Coronary Disease (Coronary Heart Disease)
07/2005 - 07/2004
1Type 2 Diabetes Mellitus (MODY)
06/2020
1Acute Coronary Syndrome
01/2017
1Mood Disorders (Mood Disorder)
08/2005

Drug/Important Bio-Agent (IBA)

34-nitro-3-dimethylaminopropiophenoneIBA
11/2021 - 01/2019
3Antidepressive Agents (Antidepressants)IBA
07/2005 - 06/2003
2Biological ProductsIBA
11/2018 - 08/2005
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2017
1CholesterolIBA
01/2017
1Sertraline (Zoloft)FDA LinkGeneric
07/2004
1Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
06/2003

Therapy/Procedure

1Stents
01/2017